Cargando…
Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure
BACKGROUND: Heart failure (HF) is characterized by unfavorable prognosis. Disease trajectory of HF, however, may vary, and risk assessment of patients remains elusive. In our study, we sought to determine the prognostic impact of endocan—a novel biomarker of endothelial dysfunction and low-grade inf...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476001/ https://www.ncbi.nlm.nih.gov/pubmed/31089401 http://dx.doi.org/10.1155/2019/9134096 |
_version_ | 1783412828951019520 |
---|---|
author | Kosir, Gorazd Jug, Borut Novakovic, Marko Mijovski, Mojca Bozic Ksela, Jus |
author_facet | Kosir, Gorazd Jug, Borut Novakovic, Marko Mijovski, Mojca Bozic Ksela, Jus |
author_sort | Kosir, Gorazd |
collection | PubMed |
description | BACKGROUND: Heart failure (HF) is characterized by unfavorable prognosis. Disease trajectory of HF, however, may vary, and risk assessment of patients remains elusive. In our study, we sought to determine the prognostic impact of endocan—a novel biomarker of endothelial dysfunction and low-grade inflammation—in patients with heart failure. METHODS: In outpatients with chronic HF, baseline values of endocan were determined and clinical follow-up for a minimum of 18 months obtained. A multivariate Cox proportional hazard model was built for HF-related death or hospitalization requiring inotropic support. RESULTS: A total of 120 patients (mean age 71 years, 64% male, mean LVEF 36%) were included. During a mean follow-up of 656 ± 109 days, 50 patients (41.6%) experienced an event. On Cox multivariate analysis, endocan values emerged as an independent predictor of HF prognosis (HR, 1.471 CI 95% 1.183-1.829, p = 0.001, for each 1 ng/mL increase) even after adjustment for age, gender, HF etiology, LVEF, NYHA class, NT-proBNP, and exercise tolerance. CONCLUSIONS: Endocan is an independent predictor of HF-related events in chronic HF individuals and represents a promising tool for risk assessment of HF patients. |
format | Online Article Text |
id | pubmed-6476001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-64760012019-05-14 Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure Kosir, Gorazd Jug, Borut Novakovic, Marko Mijovski, Mojca Bozic Ksela, Jus Dis Markers Research Article BACKGROUND: Heart failure (HF) is characterized by unfavorable prognosis. Disease trajectory of HF, however, may vary, and risk assessment of patients remains elusive. In our study, we sought to determine the prognostic impact of endocan—a novel biomarker of endothelial dysfunction and low-grade inflammation—in patients with heart failure. METHODS: In outpatients with chronic HF, baseline values of endocan were determined and clinical follow-up for a minimum of 18 months obtained. A multivariate Cox proportional hazard model was built for HF-related death or hospitalization requiring inotropic support. RESULTS: A total of 120 patients (mean age 71 years, 64% male, mean LVEF 36%) were included. During a mean follow-up of 656 ± 109 days, 50 patients (41.6%) experienced an event. On Cox multivariate analysis, endocan values emerged as an independent predictor of HF prognosis (HR, 1.471 CI 95% 1.183-1.829, p = 0.001, for each 1 ng/mL increase) even after adjustment for age, gender, HF etiology, LVEF, NYHA class, NT-proBNP, and exercise tolerance. CONCLUSIONS: Endocan is an independent predictor of HF-related events in chronic HF individuals and represents a promising tool for risk assessment of HF patients. Hindawi 2019-04-04 /pmc/articles/PMC6476001/ /pubmed/31089401 http://dx.doi.org/10.1155/2019/9134096 Text en Copyright © 2019 Gorazd Kosir et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kosir, Gorazd Jug, Borut Novakovic, Marko Mijovski, Mojca Bozic Ksela, Jus Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure |
title | Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure |
title_full | Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure |
title_fullStr | Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure |
title_full_unstemmed | Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure |
title_short | Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure |
title_sort | endocan is an independent predictor of heart failure-related mortality and hospitalizations in patients with chronic stable heart failure |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476001/ https://www.ncbi.nlm.nih.gov/pubmed/31089401 http://dx.doi.org/10.1155/2019/9134096 |
work_keys_str_mv | AT kosirgorazd endocanisanindependentpredictorofheartfailurerelatedmortalityandhospitalizationsinpatientswithchronicstableheartfailure AT jugborut endocanisanindependentpredictorofheartfailurerelatedmortalityandhospitalizationsinpatientswithchronicstableheartfailure AT novakovicmarko endocanisanindependentpredictorofheartfailurerelatedmortalityandhospitalizationsinpatientswithchronicstableheartfailure AT mijovskimojcabozic endocanisanindependentpredictorofheartfailurerelatedmortalityandhospitalizationsinpatientswithchronicstableheartfailure AT kselajus endocanisanindependentpredictorofheartfailurerelatedmortalityandhospitalizationsinpatientswithchronicstableheartfailure |